Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Chronic and Acute Nicotine Exposure Versus Placebo in Smokers and Nonsmokers — Samantha J. Brooks (2017) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Chronic and Acute Nicotine Exposure Versus Placebo in Smokers and Nonsmokers
Shared by
Dan Joseph Stein
Chronic and Acute Nicotine Exposure Versus Placebo in Smokers and Nonsmokers
Chapter In A Book
2017
en
Authors
SB
Samantha J. Brooks
JI
Jonathan Ipser
Dan Joseph Stein
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2003
Olanzapine Versus Placebo in Acute Mania
Ross J. Baldessarini
,
John Hennen
,
Michael G. Wilson
,
Joseph R. Calabrese
,
Roy Chengappa
,
Paul E. Keck
,
Susan L. McElroy
,
Gary Sachs
,
Eduard Vieta
,
Jeffrey A. Welge
,
Lakshmi N. Yatham
,
Carlos A. Zarate
,
Robert W. Baker
,
Mauricio Tohen
Letter
2009
Carbimazole Treatment in Smokers vs Nonsmokers With Graves Disease
Jae Il Shin
Article
2011
Biomarkers of oxidative damage in cigarette smokers: Which biomarkers might reflect acute versus chronic oxidative stress?
Raymond C.S. Seet
,
Jetty Chung‐Yung Lee
,
Wai Mun Loke
,
Shan Huang
,
Hui-Wen Huang
,
Woan Foon Looi
,
Eng Soh Chew
,
Amy M.L. Quek
,
Erle C.H. Lim
,
Barry Halliwell
Free Radical Biology and Medicine
Article
2008
Heparin versus placebo for acute coronary syndromes
Kirk Magee
,
Samuel Campbell
,
David Moher
,
Brian H. Rowe
Article
2010
Heparin versus placebo for acute coronary syndromes (Review)
Kirk Magee
,
Campbell Sg
,
David Moher
,
Rowe Bh
Discussion(0)
No comments yet. Be the first to comment.